Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for GoHealth (GOCO) over the last 7 years, with Q3 2025 value amounting to $277.2 million.

  • GoHealth's Other Operating Expenses rose 18209.9% to $277.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $750.0 million, marking a year-over-year increase of 5601.51%. This contributed to the annual value of $501.4 million for FY2024, which is 245.85% down from last year.
  • As of Q3 2025, GoHealth's Other Operating Expenses stood at $277.2 million, which was up 18209.9% from $145.3 million recorded in Q2 2025.
  • Over the past 5 years, GoHealth's Other Operating Expenses peaked at $720.5 million during Q4 2021, and registered a low of $90.8 million during Q2 2024.
  • Its 5-year average for Other Operating Expenses is $172.8 million, with a median of $136.0 million in 2021.
  • Per our database at Business Quant, GoHealth's Other Operating Expenses plummeted by 8448.12% in 2022 and then skyrocketed by 18209.9% in 2025.
  • Over the past 5 years, GoHealth's Other Operating Expenses (Quarter) stood at $720.5 million in 2021, then crashed by 84.48% to $111.8 million in 2022, then soared by 49.18% to $166.8 million in 2023, then increased by 12.42% to $187.5 million in 2024, then soared by 47.83% to $277.2 million in 2025.
  • Its Other Operating Expenses was $277.2 million in Q3 2025, compared to $145.3 million in Q2 2025 and $139.9 million in Q1 2025.